Publications 2010

Joannides R, Etienne I, Iacob M, De Ligny BH, Barbier S, Bellien J, Lebranchu Y, Thuillez C, Godin M. Comparative effects of sirolimus and cyclosporin on conduit arteries endothelial function in kidney recipients.Transpl Int. 2010 Nov;23(11):1135-43.

Gaber AO, Monaco AP, Russell JA, Lebranchu Y, Mohty M. 2010. Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology. Drugs.70:691-732.

Weir MR, Diekmann F, Flechner SM, Lebranchu Y, Mandelbrot DA, Oberbauer R, Kahan BD. 2010. mTOR inhibition: the learning curve in kidney transplantation. Transpl Int.23:447-60.

Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P. 2010. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant.10:1228-37

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C. 2010. Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. J Med Genet.47:54-8

Lemoine R, Velge-Roussel F, Herr F, Felix R, Nivet H, Lebranchu Y, Baron C. 2010. Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity. Blood in press 116:3089-98.

Faugaret D, Lemoine R, Baron C, Lebranchu Y, Velge-Roussel F. 2010. Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-alpha and lipopolysaccharide through a different modulation of MAPK signaling. Mol Immunol 47:1848-59.

Baron C, Forconi C, Lebranchu Y. Revisiting the effects of CMV on long-term transplant outcome. Curr Opin Organ Transplant. 2010 Aug;15(4):492-8. PMID:20631617 [PubMed - indexed for MEDLINE]